Apoa1, a major component of high-density lipoprotein known to improve glucose clearance and insulin sensitivity, was reduced in the NAFLD and NASH groups (40, 41). The gene discussed is APOA1; the disease is metabolic dysfunction-associated steatotic liver disease.